Transphorm, Inc. Common Stock
TGAN
TGAN was delisted on the 20th of June, 2024.
43 hedge funds and large institutions have $198M invested in Transphorm, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
13% more funds holding
Funds holding: 38 → 43 (+5)
8% more capital invested
Capital invested by funds: $183M → $198M (+$14.9M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$413K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$263K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$78K |
| 4 |
Bank of New York Mellon
New York
|
+$66.9K |
| 5 |
E
Ergoteles
New York
|
+$66.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$962K |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$156K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$83.3K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$30.5K |
| 5 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
-$29.4K |
TGAN Hedge Fund Activity: Q4 2022 in Review
43 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Transphorm, Inc. Common Stock (TGAN) for Q4 2022, worth a combined $198M — up 8.2% from $183M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new TGAN positions and 2 closed out — a net gain of 5 holders — while 14 added to existing stakes and 14 trimmed.
The largest buyer was BlackRock, adding an estimated $413K. The largest seller was AIGH Capital Management, cutting an estimated $962K.
- 43 institutional investors held Transphorm, Inc. Common Stock (TGAN) as of Q4 2022, up from 38 in Q3 2022.
- Funds reported $198M of Transphorm, Inc. Common Stock stock for Q4 2022, up 8.2% quarter-over-quarter.
- 7 funds opened new Transphorm, Inc. Common Stock positions in Q4 2022 and 2 closed out, a net change of +5 holders.
- The largest Transphorm, Inc. Common Stock buyer in Q4 2022 was BlackRock, an estimated $413K added.
- The largest Transphorm, Inc. Common Stock seller in Q4 2022 was AIGH Capital Management, an estimated $962K sold.
Based on aggregated 13F filings for Q4 2022.